Відродження після кризи: майбутні стратегії компаній у фармацевтичній галузі

It is no secret that Uzbekistan has established effective cooperation with many countries of the world in the development of the pharmaceutical industry, in particular, supplying our people with high-quality…

Investment of 350 million EUR in state-of-the-art research infrastructure is Boehringer Ingelheim’s largest single investment in Germany to date Boehringer Ingelheim strengthens innovation power and development of biopharmaceuticals, which account…